help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Risbridger, G. P.
Right arrow Articles by de Kretser, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Risbridger, G. P.
Right arrow Articles by de Kretser, D. M.

Endocrinology, Vol 110, 138-145, Copyright © 1982 by Endocrine Society


ARTICLES

The effects of chronic human chorionic gonadotropin treatment on Leydig cell function

GP Risbridger, DM Robertson and DM de Kretser

The purpose of this study was to examine the effect of chronic daily hCG treatment on interstitial cell function in the rat, as judged by plasma testosterone levels, the testicular binding of labeled hCG, and the capacity of the testis to respond to gonadotropin stimulation by the production of testosterone in vitro. TWenty-four hours after the first injection of 100 IU hCG there was a significant decline in hCG binding to testis homogenates and an inability to respond to hCG stimulation in vitro, After 7 days of daily injections of 10 IU or 100 IU hCG, the loss of hCG binding was maintained. However, despite the marked decline in hCG binding, there was an enhanced testosterone response to hCG stimulation in vitro, and plasma testosterone levels were significantly elevated. With continued injections of hCG for 14 or 21 days, the testes remained hyperresponsive to hCG stimulation in vitro, but hCG binding returned to control levels, and plasma testosterone concentrations declined and were not statistically different from controls. The latter changes probably result from the formation of specific hCG antibodies (Kd at 4 C, 7.8 +/- 4.5 X 10(-10) M) that were detected in plasma from rats treated for 14 or mopre days with hCG. The formation and levels of the hCG antibodies in these animals were sufficient to neutralize the effects of the exogenous hCG, thereby returning plasma testosterone levels to normal and restoring the complement of hCG receptors.


This article has been cited by other articles:


Home page
ReproductionHome page
S. B Rulli and I. Huhtaniemi
What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?
Reproduction, September 1, 2005; 130(3): 283 - 291.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. A. Spaliviero, M. Jimenez, C. M. Allan, and D. J. Handelsman
Luteinizing Hormone Receptor-Mediated Effects on Initiation of Spermatogenesis in Gonadotropin-Deficient (hpg) Mice Are Replicated by Testosterone
Biol Reprod, January 1, 2004; 70(1): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. B. Rulli, P. Ahtiainen, S. Makela, J. Toppari, M. Poutanen, and I. Huhtaniemi
Elevated Steroidogenesis, Defective Reproductive Organs, and Infertility in Transgenic Male Mice Overexpressing Human Chorionic Gonadotropin
Endocrinology, November 1, 2003; 144(11): 4980 - 4990.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Haywood, J. Spaliviero, M. Jimemez, N. J. C. King, D. J. Handelsman, and C. M. Allan
Sertoli and Germ Cell Development in Hypogonadal (hpg) Mice Expressing Transgenic Follicle-Stimulating Hormone Alone or in Combination with Testosterone
Endocrinology, February 1, 2003; 144(2): 509 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. Reaven, L. Zhan, A. Nomoto, S. Leers-Sucheta, and S. Azhar
Expression and microvillar localization of scavenger receptor class B, type I (SR-BI) and selective cholesteryl ester uptake in Leydig cells from rat testis
J. Lipid Res., March 1, 2000; 41(3): 343 - 356.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society